Medical Technology

@xconomy.com 4 years ago

Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More

@xconomy.com 4 years ago

Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal

@xconomy.com 4 years ago

Invitae Offers $55M for Singular Bio to Expand Prenatal Test Business

@xconomy.com 5 years ago

Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B

@xconomy.com 5 years ago

Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M

@xconomy.com 5 years ago

With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?

@xconomy.com 6 years ago

United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed